This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Russelakis-Carneiro, M. Articles by Soto, C. Search for Related Content PubMed PubMed Citation Articles by Russelakis-Carneiro, M. Articles by Soto, C.

(American Journal of Pathology. 2004;165:1839-1848.)
© 2004 American Society for Investigative Pathology

Prion Replication Alters the Distribution of Synaptophysin and Caveolin 1 in Neuronal Lipid Rafts

Milene Russelakis-Carneiro^*, Claudio Hetz^*, Kinsey Maundrell^* and Claudio Soto^*

From the Serono Pharmaceutical Research Institute,^* Geneva, Switzerland; the Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile; and the Department of Neurology, University of Texas Medical Branch, Galveston, Texas

The main event in the pathogenesis of prion diseases is the conversion of the cellular prion protein (PrP^C) into the abnormal, protease-resistant prion protein (PrP^res). PrP^C is a GPI-anchored protein located in lipid rafts or detergent-resistant membranes (DRMs). Here we describe the association of PrP with DRMs in neuronal cell bodies and axons during the course of murine scrapie and its relation with the distribution of the PrP-interacting proteins caveolin 1 and synaptophysin. Scrapie infection triggered the accumulation of PrP^res in DRMs from retinas and optic nerves from early stages of the disease before evidence of neuronal cell loss. Most of the PrP^res remained associated with lipid rafts throughout different stages in disease progression. In contrast to PrP^res, caveolin 1 and synaptophysin in retina and optic nerves shifted to non-DRM fractions during the course of scrapie infection. The accumulation of PrP^res in DRMs was not associated with a general alteration in their composition, because no change in the total protein distribution across the sucrose gradient or in the flotation characteristics of the glycosphingolipid GM1 or Thy-1 were observed until advanced stages of the disease. However, an increase in total cholesterol levels was observed in optic nerve and retinas. Only during late stages of the disease was a decrease in the number of neuronal cell bodies observed, suggesting that synaptic abnormalities are the earliest sign of neuronal dysfunction that ultimately results in neuronal death. These results indicate that prion replication triggers an abnormal localization of caveolin 1 and synaptophysin, which in turn may alter neuronal function.

This article has been cited by other articles:

				A. Pani, C. Norfo, C. Abete, C. Mulas, M. Putzolu, S. Laconi, C. D. Orru, M. D. Cannas, S. Vascellari, P. La Colla, et al. Antiprion Activity of Cholesterol Esterification Modulators: a Comparative Study Using Ex Vivo Sheep Fibroblasts and Lymphocytes and Mouse Neuroblastoma Cell Lines Antimicrob. Agents Chemother., November 1, 2007; 51(11): 4141 - 4147. [Abstract] [Full Text] [PDF]

				M. Fuhrmann, G. Mitteregger, H. Kretzschmar, and J. Herms Dendritic Pathology in Prion Disease Starts at the Synaptic Spine J. Neurosci., June 6, 2007; 27(23): 6224 - 6233. [Abstract] [Full Text] [PDF]

				C. Hetz, J. Castilla, and C. Soto Perturbation of Endoplasmic Reticulum Homeostasis Facilitates Prion Replication J. Biol. Chem., April 27, 2007; 282(17): 12725 - 12733. [Abstract] [Full Text] [PDF]

				J. J. Greenlee, A. N. Hamir, and M. H. West Greenlee Abnormal prion accumulation associated with retinal pathology in experimentally inoculated scrapie-affected sheep. Vet. Pathol., September 1, 2006; 43(5): 733 - 739. [Abstract] [Full Text] [PDF]